Delivery Order SPE2DB22D1017-SPE2DB25FF5LH

Award Date 2/13/25
Potential Completion Date 2/14/25
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,460.54, is for the delivery of teriparatide 600 mcg/2.4 ml pens to support military healthcare programs. The contract is a Firm Fixed Price Delivery Order with a period of performance through February 4, 2025. There is no set-aside designation indicated for this award. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,006.22, is a delivery order for the supply of 4566407301 - TERIPARATIDE 600 MCG/2.4ML PEN 2.4ML. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,484.91, is for the delivery of the medication TERIPARATIDE 600 MCG/2.4ML PEN 2.4ML. It is a firm fixed-price delivery order contract with a completion date of January 7, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is a Delivery Order with a Firm Fixed Price, valued at $5,510.61, for the delivery of 4567171361 - TERIPARATIDE 600 MCG/2.4ML PEN 2.4ML, a specialty medication. The contract has an ultimate completion date of February 6, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $29,830.25 firm fixed-price delivery order is for the supply of 4,566,054,436 units of the drug Teriparatide 600 mcg/2.4 ml pen. The contract has an ultimate completion date of October 9, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,439.01 firm fixed-price delivery order contract is for the procurement of 4566383566 TERIPARATIDE 600 MCG/2.4ML PEN 2.4ML, with a completion date of November 12, 2024. The contract is not designated under any set-aside program. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract, valued at $2,591.28, is for the delivery of teriparatide 600 mcg/2.4 ml pens. The contract is a firm fixed-price delivery order that was awarded without the use of a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The $25,398.47 firm-fixed-price contract is for the delivery of Teriparatide 600 mcg/2.4 ml pens. This order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, to provide a comprehensive range of medical commodities to...
This is a $21,502.81 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract provides TERIPARATIDE 600 MCG/2.4ML PEN 2.4ML, a specialized medication, and does not have a set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, identified as SPE2DB22D1002|SPE2DB25FKUZ7, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,678.19 firm fixed-price delivery order is for the supply of 4,566,597,194 units of the medication teriparatide 600 mcg/2.4 ml pen. This award does not have a set-aside designation, indicating open competition. The contract is a delivery order placed under...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FF5LH
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,889.89, is for the delivery of 4567268920 teriparatide 600 mcg/2.4 ml pens.

The award is a delivery order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen is the prime contractor, and the place of performance is Conshohocken, PA. As a major pharmaceutical distributor, Amerisourcebergen plays a critical role in supplying medical products to federal government agencies, including the military and veterans' healthcare systems.

Generated 5/22/25, 8:10 PM